Loading clinical trials...
Loading clinical trials...
Fiber Supplementation to Increase Short Chain Fatty Acid Production in Patients With Type II Diabetes and Heart Failure With Preserved Ejection Fraction - the FERMENT HFpEF Trial
The study team is studying how increasing dietary fiber, specifically through adding potato starch to participant's diet, may impact the species of bacteria in participant's gut microbiome. The study team also wants to understand if adding potato starch to participant's diet helps these bacteria make more short chain fatty acids, a byproduct the team thinks may benefit participant's health.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Michigan
Ann Arbor, Michigan, United States
Start Date
April 1, 2024
Primary Completion Date
June 1, 2026
Completion Date
December 1, 2026
Last Updated
July 24, 2025
30
ESTIMATED participants
Potato Starch
DIETARY_SUPPLEMENT
Lead Sponsor
University of Michigan
NCT07057466
NCT07093528
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions